Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Patients With Resectable or Locally Advanced Gastric or Gastro-oesophageal Junction Cancer

NCT03957564 is registered in ClinicalTrials.gov with Affiliated Hospital of Qinghai University as lead sponsor.

NCT NCT03957564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03957564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Patients With Resectable or Locally Advanced Gastric or Gastro-oesophageal Junction Cancer
Lead sponsor
Affiliated Hospital of Qinghai University
Phase
Phase 2
Overall status
Unknown status
Start date
May 28, 2019
Completion date
May 20, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, gastro-oesophageal junction cancer